Not yet recruiting NCT05637892
A Cohort Study of Hydatidiform Mole
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No intervention.
- Who it may be relevant to
- Registry conditions: Hydatidiform Mole. Basic parameters: 13 years — 55 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Multi-center Cohort Study of Hydatidiform Mole
Overview
The purpose of this study is to construct a cohort for the hydatidiform mole.
Detailed description
After being informed about the study and potential risks, all patients who meet the eligibility requirements will be enrolled.
Interventions
- Other No intervention
This is a prospective observational study with no intervention
Primary outcome measures
- Malignant trophoblastic tumor [Time frame: 4.5 years]
Eligibility criteria
Inclusion criteria
- Patients who are diagnosed with hydatidiform mole (including: complete hydatidiform mole/partial hydatidiform mole; one of twins with hydatidiform mole; ectopic pregnancy hydatidiform mole; macroscopic or microscopic hydatidiform changes indicating early complete or partial hydatidiform mole can not be excluded; atypical placental site nodule) for the first time;
- Age 13-55 years old;
- Obtain informed consent and sign an informed consent form
Exclusion criteria
- Patients who are unable to cooperate with the investigation such as mental disorders or cognitive impairment
- No histopathology diagnosis;
- Patients with other malignancies
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT05637892 · IRB-20220312-R